618 related articles for article (PubMed ID: 9721873)
1. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
Booth CL; Brouwer KR; Brouwer KL
Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.
Hoffmaster KA; Zamek-Gliszczynski MJ; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1203-10. PubMed ID: 15302892
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.
Sparreboom A; Planting AS; Jewell RC; van der Burg ME; van der Gaast A; de Bruijn P; Loos WJ; Nooter K; Chandler LH; Paul EM; Wissel PS; Verweij J
Anticancer Drugs; 1999 Sep; 10(8):719-28. PubMed ID: 10573204
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
Booth CL; Pollack GM; Brouwer KL
Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
[TBL] [Abstract][Full Text] [Related]
6. A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
Planting AS; Sonneveld P; van der Gaast A; Sparreboom A; van der Burg ME; Luyten GP; de Leeuw K; de Boer-Dennert M; Wissel PS; Jewell RC; Paul EM; Purvis NB; Verweij J
Cancer Chemother Pharmacol; 2005 Jan; 55(1):91-9. PubMed ID: 15565444
[TBL] [Abstract][Full Text] [Related]
7. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
Ward ES; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
[TBL] [Abstract][Full Text] [Related]
8. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918.
Wu CY; Benet LZ
Drug Metab Dispos; 2003 Nov; 31(11):1292-5. PubMed ID: 14570757
[TBL] [Abstract][Full Text] [Related]
9. Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level.
Smit JW; Duin E; Steen H; Oosting R; Roggeveld J; Meijer DK
Br J Pharmacol; 1998 Feb; 123(3):361-70. PubMed ID: 9504375
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
Ellis AG; Crinis NA; Webster LK
Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
Wallstab A; Koester M; Böhme M; Keppler D
Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL.
Ellis AG; Webster LK
Cancer Chemother Pharmacol; 1999; 43(1):13-8. PubMed ID: 9923536
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes.
Annaert PP; Turncliff RZ; Booth CL; Thakker DR; Brouwer KL
Drug Metab Dispos; 2001 Oct; 29(10):1277-83. PubMed ID: 11560870
[TBL] [Abstract][Full Text] [Related]
15. Effect of various cytochrome P450 3A and P-glycoprotein modulators on the biliary clearance of bromosulphaphthalein in male wistar rats.
Machavaram KK; Gundu J; Yamsani MR
Pharmazie; 2004 Dec; 59(12):957-60. PubMed ID: 15638086
[TBL] [Abstract][Full Text] [Related]
16. Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver.
Chandra P; Johnson BM; Zhang P; Pollack GM; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1238-43. PubMed ID: 15908472
[TBL] [Abstract][Full Text] [Related]
17. Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers.
Parasrampuria R; Mehvar R
J Pharm Sci; 2010 Jan; 99(1):455-66. PubMed ID: 19499568
[TBL] [Abstract][Full Text] [Related]
18. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
19. Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers.
Parasrampuria R; Shaik IH; Mehvar R
J Pharm Pharm Sci; 2012; 15(2):318-28. PubMed ID: 22579010
[TBL] [Abstract][Full Text] [Related]
20. Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin.
Choi YH; Lee YK; Lee MG
Xenobiotica; 2013 Oct; 43(10):901-7. PubMed ID: 23574017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
